NCT05461456 Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% Status COMPLETED Phase PHASE1
NCT05439577 A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema Status UNKNOWN Phase N/A
NCT05413395 Assessment of the Effects on the Skin Microbiome of Amending an Over-the-counter Eczema Product With Activated Oil (AO) Status UNKNOWN Phase NA
NCT05330637 Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China. Status UNKNOWN Phase N/A
NCT05265234 Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. Status UNKNOWN Phase PHASE4
NCT05149313 A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine Status COMPLETED Phase PHASE3
NCT05131477 Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study Status COMPLETED Phase PHASE2
NCT04986384 Effect of a Topical Spray on Itch Relief in Moderate-to-severe Childhood Eczema Status COMPLETED Phase NA
NCT04965233 Using a Telemedicine Approach in a Genome-wide Association Study of Atopic Dermatitis - Searching for Novel Biomarkers in Clinically Relevant Phenotypes Status WITHDRAWN Phase N/A
NCT04919330 Acceptance and Commitment Therapy-based Eczema Management Programme Status COMPLETED Phase NA
NCT04818138 BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort Status TERMINATED Phase NA
NCT04809571 Non-invasive Photoacoustic Imaging of Skin Inflammatory Disorders With Machine Learning-assisted Scoring Status UNKNOWN Phase NA
NCT04800315 A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT04760314 A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT04617977 Integrative Body-Mind-Spirit Intervention for Families With Children Suffering From Eczema Status UNKNOWN Phase NA
NCT04520308 An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis Status UNKNOWN Phase PHASE4